Literature DB >> 31144289

Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults.

Virawudh Soontornniyomkij1, David J Moore2, Ben Gouaux2, Benchawanna Soontornniyomkij2, Janet S Sinsheimer3, Andrew J Levine4.   

Abstract

With increasing age, the general population is increasingly vulnerable to the development of cerebral amyloid-β (Aβ) plaque and neuronal phospho-tau (p-tau) pathology. In HIV disease, prior studies of these neuropathologic changes were relatively limited. Here, we characterized Aβ plaques and p-tau lesions by immunohistochemistry in relevant brain regions (prefrontal neocortex, putamen, basal-temporal neocortex, and hippocampus) of HIV-infected adults. We used multivariable logistic regression to predict regional Aβ plaque or p-tau pathology based on demographic factors, apolipoprotein E (APOE) genotypes, HIV disease-related factors, and regional gliosis. We used multiple linear regression to predict T-scores in neuropsychological domains based on regional Aβ plaque or p-tau pathology. We found that APOE ε4 alleles, older age, and higher plasma HIV-1 RNA predicted prefrontal Aβ plaques (odds ratio (OR) 5.306, 1.045, and 0.699, respectively, n = 168). Older age predicted putamen Aβ plaques (OR 1.064, n = 171). APOE ε4 alleles, hepatitis C virus seropositivity, and higher plasma HIV-1 RNA predicted hippocampus Aβ plaques (OR 6.779, 6.138, and 0.589, respectively, n = 56). The p-tau lesions were sparse in the vast majority of affected cases. Lifetime substance use disorder and higher plasma HIV-1 RNA predicted putamen p-tau lesions (OR 0.278 and 0.638, respectively, n = 67). Older age and gliosis predicted hippocampus p-tau lesions (OR 1.128 and 0.592, respectively, n = 59). Prefrontal Aβ plaques predicted lower speed of information processing (n = 159) and putamen Aβ plaques predicted lower levels of attention and working memory (n = 88). Regional p-tau lesions were not significantly predictive of any neuropsychological domains. In conclusion, Aβ plaque or p-tau pathology in different brain regions was predicted by different sets of biological factors. Aβ plaques in prefrontal neocortex and putamen predicted poorer functioning in cognitive domains relevant to these brain regions. The absence of significant impact of regional p-tau lesions on neuropsychological functioning might be explained by the subthreshold burden of p-tau lesions.

Entities:  

Keywords:  Amyloidosis; Astrogliosis; Gliosis; Microgliosis; Neurodegeneration; Tauopathy

Year:  2019        PMID: 31144289      PMCID: PMC6883131          DOI: 10.1007/s13365-019-00761-y

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  39 in total

1.  Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Authors:  Joseph L Price; Daniel W McKeel; Virginia D Buckles; Catherine M Roe; Chengjie Xiong; Michael Grundman; Lawrence A Hansen; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Charles D Smith; Daron G Davis; Frederick A Schmitt; William R Markesbery; Jeffrey Kaye; Roger Kurlan; Christine Hulette; Brenda F Kurland; Roger Higdon; Walter Kukull; John C Morris
Journal:  Neurobiol Aging       Date:  2009-04-18       Impact factor: 4.673

2.  Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS).

Authors:  E Izycka-Swieszewska; A Zółtowska; R Rzepko; M Gross; J Borowska-Lehman
Journal:  Folia Neuropathol       Date:  2000       Impact factor: 2.038

Review 3.  Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.

Authors:  Dietmar Rudolf Thal; Jochen Walter; Takaomi C Saido; Marcus Fändrich
Journal:  Acta Neuropathol       Date:  2014-12-23       Impact factor: 17.088

4.  Training improves multitasking performance by increasing the speed of information processing in human prefrontal cortex.

Authors:  Paul E Dux; Michael N Tombu; Stephenie Harrison; Baxter P Rogers; Frank Tong; René Marois
Journal:  Neuron       Date:  2009-07-16       Impact factor: 17.173

Review 5.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

Review 6.  Classification and basic pathology of Alzheimer disease.

Authors:  Charles Duyckaerts; Benoît Delatour; Marie-Claude Potier
Journal:  Acta Neuropathol       Date:  2009-04-21       Impact factor: 17.088

7.  The spectrum of disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Robert A Stern; Christopher J Nowinski; Thor D Stein; Victor E Alvarez; Daniel H Daneshvar; Hyo-Soon Lee; Sydney M Wojtowicz; Garth Hall; Christine M Baugh; David O Riley; Caroline A Kubilus; Kerry A Cormier; Matthew A Jacobs; Brett R Martin; Carmela R Abraham; Tsuneya Ikezu; Robert Ross Reichard; Benjamin L Wolozin; Andrew E Budson; Lee E Goldstein; Neil W Kowall; Robert C Cantu
Journal:  Brain       Date:  2012-12-02       Impact factor: 13.501

8.  Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.

Authors:  David A Bennett; Philip L De Jager; Sue E Leurgans; Julie A Schneider
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

9.  Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.

Authors:  Steven Paul Woods; Julie D Rippeth; Alan B Frol; Joel K Levy; Elizabeth Ryan; Vicki M Soukup; Charles H Hinkin; Deborah Lazzaretto; Mariana Cherner; Thomas D Marcotte; Benjamin B Gelman; Susan Morgello; Elyse J Singer; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-09       Impact factor: 2.475

10.  HIV-1 Infection Accelerates Age According to the Epigenetic Clock.

Authors:  Steve Horvath; Andrew J Levine
Journal:  J Infect Dis       Date:  2015-05-12       Impact factor: 5.226

View more
  8 in total

Review 1.  Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.

Authors:  Patricia K Riggs; Antoine Chaillon; Guochun Jiang; Scott L Letendre; Yuyang Tang; Jeff Taylor; Andrew Kaytes; Davey M Smith; Karine Dubé; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-19       Impact factor: 5.495

2.  Distinguishing Amnestic Mild Cognitive Impairment From HIV-Associated Neurocognitive Disorders.

Authors:  Erin E Sundermann; Mark W Bondi; Laura M Campbell; Ben Gouaux; Raeanne C Moore; Virawudh Soontornniyomkij; David J Moore
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

3.  HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition.

Authors:  Susan Morgello; Etty P Cortes; Gary Gensler; Gregory Meloni; Michelle M Jacobs; Jacinta Murray; Valeriy Borukov; John F Crary
Journal:  AIDS       Date:  2021-07-15       Impact factor: 4.632

Review 4.  Extracellular Vesicles: A Possible Link between HIV and Alzheimer's Disease-Like Pathology in HIV Subjects?

Authors:  Sunitha Kodidela; Kelli Gerth; Sanjana Haque; Yuqing Gong; Saifudeen Ismael; Ajay Singh; Ishrat Tauheed; Santosh Kumar
Journal:  Cells       Date:  2019-08-24       Impact factor: 6.600

5.  CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.

Authors:  Biju Bhargavan; Shawna M Woollard; Jo Ellyn McMillan; Georgette D Kanmogne
Journal:  Mol Neurodegener       Date:  2021-11-22       Impact factor: 14.195

6.  HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner.

Authors:  Claudia Lopez Lloreda; Sarah Chowdhury; Shivesh Ghura; Elena Alvarez-Periel; Kelly Jordan-Sciutto
Journal:  Cells       Date:  2022-09-22       Impact factor: 7.666

Review 7.  Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV.

Authors:  Bradley Nash; Elena Irollo; Renato Brandimarti; Olimpia Meucci
Journal:  Methods Mol Biol       Date:  2021

8.  Brain amyloid in virally suppressed HIV-associated neurocognitive disorder.

Authors:  Gemma C Howdle; Yann Quidé; Mustafa S Kassem; Kate Johnson; Caroline D Rae; Bruce J Brew; Lucette A Cysique
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-05-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.